Sharon Benzeno

Companies

• Adaptive BiotechnologiesSr VP, Drug Discovery Jun 26, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAdaptive Biotechnologies ADPT221,278 shares²$5.3M at $24.01Jun 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 29, 2026Sold 154,768 shares at $21.14 of Adaptive Biotechnologies²
• Jun 29, 2026Exercised options 51,570 shares at $8.12 of Adaptive Biotechnologies²
• Jun 29, 2026Exercised options 24,944 shares at $3.99 of Adaptive Biotechnologies²
• Jun 29, 2026Exercised options 24,944 shares at $8.46 of Adaptive Biotechnologies²
• Jun 29, 2026Exercised options 1,837 shares at $12.14 of Adaptive Biotechnologies²
• Jun 26, 2026Sold 11,034 shares at $21.00 of Adaptive Biotechnologies²
• Jun 26, 2026Exercised options 11,034 shares at $12.14 of Adaptive Biotechnologies²
• Mar 11, 2026Sold 63,103 shares at $13.17 of Adaptive Biotechnologies³
• Mar 4, 2026Granted 39,063 shares of Adaptive Biotechnologies⁴
• Dec 4, 2025Sold 12,604 shares at $16.85 of Adaptive Biotechnologies⁵
• Dec 4, 2025Exercised options 4,157 shares at $3.99 of Adaptive Biotechnologies⁵
• Dec 4, 2025Exercised options 4,157 shares at $8.46 of Adaptive Biotechnologies⁵
• Dec 4, 2025Exercised options 4,290 shares at $12.14 of Adaptive Biotechnologies⁵
• Nov 21, 2025Sold 308,477 shares at $16.91 of Adaptive Biotechnologies⁶
• Nov 21, 2025Exercised options 83,145 shares at $3.99 of Adaptive Biotechnologies⁶
• Nov 21, 2025Exercised options 119,809 shares at $12.14 of Adaptive Biotechnologies⁶
• Nov 21, 2025Exercised options 34,375 shares at $7.27 of Adaptive Biotechnologies⁶
• Nov 21, 2025Exercised options 49,480 shares at $6.55 of Adaptive Biotechnologies⁶
• Nov 21, 2025Exercised options 20,834 shares at $6.55 of Adaptive Biotechnologies⁶
• Nov 21, 2025Exercised options 834 shares at $6.27 of Adaptive Biotechnologies⁶
• Nov 20, 2025Sold 297,925 shares at $16.54 of Adaptive Biotechnologies⁶
• Nov 20, 2025Exercised options 68,961 shares at $12.14 of Adaptive Biotechnologies⁶
• Nov 20, 2025Exercised options 133,032 shares at $8.46 of Adaptive Biotechnologies⁶
• Mar 5, 2025Sold 3,065 shares at $6.99 of Adaptive Biotechnologies⁷
• Mar 5, 2025Sold 41,600 shares at $6.98 of Adaptive Biotechnologies⁷